American Shared Hospital Services (AMS)

AMEXHealth CareMedical - Care FacilitiesSnapshot 2026-10-23

$1.260.00%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge American Shared Hospital Services’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	8.63M
EPS	—	0.01
Annual ending 2026-12-31
Revenue	—	32.68M
EPS	—	-0.14

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Positive cash from operating activities	Cash from operations rose to $2.1M in 2026-Q1.	Intact	Cash from operations falls below $2.1M in 2026-Q1	Cash from operations: $2.236M FY2026-Q2; GAAP. Published target: >= $2.1M cash from operations in 2026-Q1. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 13, 20262,236,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Stabilize leadership and improve execution	A supporting condition in American Shared Hospital Services's published investment case. The stated target is No further CEO departures or major leadership disruptions in 2026.	Under Pressure	Another CEO leaves or major leadership disruption occurs in 2026	CFO departure confirmed CFO Raymond Frech resigned for personal reasons in July 2026, confirming a major leadership disruption. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth near 0% or better	A primary condition in American Shared Hospital Services's published investment case. The stated target is >= $7.1M revenue in Q2 2026.	Intact	Revenue falls below $7.1M in 2026-Q2	Revenue: $8.43M FY2026-Q2; GAAP. Published target: >= $7.1M revenue in Q2 2026. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 13, 20268,430,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 56722895-bf75-4437-b32e-83381395d0e4. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · alphavantage

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · alphavantage
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-06-09	Unavailable	Unavailable	— / 0
2026-06-10	Unavailable	Unavailable	— / 0
2026-06-11	Unavailable	Unavailable	— / 0
2026-06-12	Unavailable	Unavailable	— / 0
2026-06-13	Unavailable	Unavailable	— / 0
2026-06-14	Unavailable	Unavailable	— / 0
2026-06-15	Unavailable	Unavailable	— / 0
2026-06-16	Unavailable	Unavailable	— / 0
2026-06-17	Unavailable	Unavailable	— / 0
2026-06-18	Unavailable	Unavailable	— / 0
2026-06-19	Unavailable	Unavailable	— / 0
2026-06-21	Unavailable	Unavailable	— / 0
2026-06-23	Unavailable	Unavailable	— / 0
2026-06-24	Unavailable	Unavailable	— / 0
2026-06-25	Unavailable	Unavailable	— / 0
2026-06-26	Unavailable	Unavailable	— / 0
2026-06-28	Unavailable	Unavailable	— / 0
2026-06-29	Unavailable	Unavailable	— / 0
2026-06-30	Unavailable	Unavailable	— / 0
2026-07-02	Unavailable	Unavailable	— / 0
2026-07-03	Unavailable	Unavailable	— / 0
2026-07-04	Unavailable	Unavailable	— / 0
2026-07-05	Unavailable	Unavailable	— / 0
2026-07-06	Unavailable	Unavailable	— / 0
2026-07-07	Unavailable	Unavailable	— / 0
2026-07-29	Unavailable	Unavailable	— / 0
2026-07-30	Unavailable	Unavailable	— / 0
2026-07-31	Unavailable	Unavailable	— / 0
2026-08-01	Unavailable	Unavailable	— / 0
2026-08-02	Unavailable	Unavailable	— / 0
2026-08-03	Unavailable	Unavailable	— / 0
2026-08-04	Unavailable	Unavailable	— / 0
2026-08-05	Unavailable	Unavailable	— / 0
2026-08-06	Unavailable	Unavailable	— / 0
2026-08-08	Unavailable	Unavailable	— / 0
2026-08-09	Unavailable	Unavailable	— / 0
2026-08-10	Unavailable	Unavailable	— / 0
2026-08-11	Unavailable	Unavailable	— / 0
2026-08-12	Unavailable	Unavailable	— / 0
2026-08-13	Unavailable	Unavailable	— / 0
2026-08-14	Unavailable	Unavailable	— / 0
2026-08-15	Unavailable	Unavailable	— / 0
2026-08-16	Unavailable	Unavailable	— / 0
2026-08-19	Unavailable	Unavailable	— / 0
2026-08-20	Unavailable	Unavailable	— / 0
2026-08-21	Unavailable	Unavailable	— / 0
2026-08-22	Unavailable	Unavailable	— / 0
2026-08-23	Unavailable	Unavailable	— / 0
2026-08-24	Unavailable	Unavailable	— / 0
2026-08-25	Unavailable	Unavailable	— / 0
2026-08-26	Unavailable	Unavailable	— / 0
2026-08-27	Unavailable	Unavailable	— / 0
2026-08-28	Unavailable	Unavailable	— / 0
2026-08-29	Unavailable	Unavailable	— / 0
2026-08-30	Unavailable	Unavailable	— / 0
2026-08-31	Unavailable	Unavailable	— / 0
2026-09-01	Unavailable	Unavailable	— / 0
2026-09-02	Unavailable	Unavailable	— / 0
2026-09-03	Unavailable	Unavailable	— / 0
2026-09-04	Unavailable	Unavailable	— / 0
2026-09-05	Unavailable	Unavailable	— / 0
2026-09-06	Unavailable	Unavailable	— / 0
2026-09-07	Unavailable	Unavailable	— / 0
2026-09-08	Unavailable	Unavailable	— / 0
2026-09-09	Unavailable	Unavailable	— / 0
2026-09-10	Unavailable	Unavailable	— / 0
2026-09-11	Unavailable	Unavailable	— / 0
2026-09-12	Unavailable	Unavailable	— / 0
2026-09-14	Unavailable	Unavailable	— / 0
2026-09-15	Unavailable	Unavailable	— / 0
2026-09-16	Unavailable	Unavailable	— / 0
2026-09-17	Unavailable	Unavailable	— / 0
2026-09-18	Unavailable	Unavailable	— / 0
2026-09-19	Unavailable	Unavailable	— / 0
2026-09-20	Unavailable	Unavailable	— / 0
2026-09-21	Unavailable	Unavailable	— / 0
2026-09-22	Unavailable	Unavailable	— / 0
2026-09-23	Unavailable	Unavailable	— / 0
2026-09-24	Unavailable	Unavailable	— / 0
2026-09-25	Unavailable	Unavailable	— / 0
2026-09-26	Unavailable	Unavailable	— / 0

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	0	0	0
2026-06-01	0	0	0
2026-07-01	0	0	0
2026-08-01	0	0	0
2026-09-01	0	0	0
2026-10-01	0	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Positive cash from operating activitiesCash from operations: $2.236M
Stabilize leadership and improve executionPublished status: Under Pressure
Revenue growth near 0% or betterRevenue: $8.43M

Next proof point

Nov 12, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.6%Typical daily move · historical

Downside history

-45.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

American Shared Hospital Services outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

AMS is a high-risk healthcare growth story, not yet a proven durable compounder, because it remains loss-making and recent financial performance has been weak. The thesis is in a watch state: recent performance trails its industry group, though the evidence does not show a fresh break.

What's priced into American Shared Hospital Services

The valuation evidence calls AMS cheap versus peers, but confidence in that comparison is low. The expectations gap is negative, suggesting expectations are already cautious; the snapshot also labels pricing justified, with no fragility warning.

What the fundamentals likely do

Near term, the next earnings report is a key risk: AMS has had erratic surprises, and the estimated chance of a miss is 45%. Over the multi-year view, revenue growth in direct patient services and proton beam therapy, along with positive operating cash flow in the first half of 2026, supports progress, while the CFO transition and mixed progress on the financial position add uncertainty.

What American Shared Hospital Services hinges on

The thesis depends on AMS continuing to grow procedure volumes and clinical capacity while improving cash generation and its debt position. A guidance cut or weaker employment data would add pressure, while continued strong results and guidance from healthcare peers could support sector momentum.